QSI QUANTUM-SI INC

Quantum-Si to Participate in Upcoming Investment Conferences

BRANFORD, Conn.--(BUSINESS WIRE)--

(Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing Company™, today announced that it will be participating in two upcoming investment conferences.

Jeff Hawkins, Quantum-Si's Chief Executive Officer, will participate in a fireside chat discussion at the UBS Global Healthcare Conference on Wednesday, November 13th, at 8:45 AM PT.

On Thursday, November 21st at 8:00 AM ET, Mr. Hawkins will participate in a fireside chat discussion at the Canaccord Medtech, Diagnostics & Services Forum in New York City.

A live and archived webcast of the event will be available in the “Investors” section of the Quantum-Si website under .

About Quantum-Si Incorporated

Quantum-Si, The Protein Sequencing Company™, is focused on revolutionizing the growing field of proteomics. The Company’s Platinum® instrument enables Next-Generation Protein Sequencing™ that advances proteomic research, drug discovery, and diagnostics beyond what has been possible with existing proteomic tools. Learn more at or follow us on or .

EN
05/11/2024

Underlying

QSIQUANTUM-SI INC

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on QUANTUM-SI INC

 PRESS RELEASE
Free
QSI QUANTUM-SI INC

University of Virginia Researchers Publish New Study on Tropomyosin Pr...

BRANFORD, Conn.--(BUSINESS WIRE)-- (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing Company™, today announced a newly released preprint publication on BioRxiv, from Dr. Gloria Sheynkman at the University of Virginia School of Medicine. In the publication, Sheynkman and team demonstrate the application of Quantum-Si’s Platinum™ single-molecule benchtop sequencer to distinguish proteoform-informative peptides within the human tropomyosin (TPM) gene family. This study highlights Platinum’s ability to achieve single amino acid resolution, revealing variations that diff...

6h / 45m 1 EN
 PRESS RELEASE
Free
QSI QUANTUM-SI INC

Quantum-Si to Participate in Upcoming Investment Conferences

BRANFORD, Conn.--(BUSINESS WIRE)-- (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing Company™, today announced that it will be participating in two upcoming investment conferences. Jeff Hawkins, Quantum-Si's Chief Executive Officer, will participate in a fireside chat discussion at the UBS Global Healthcare Conference on Wednesday, November 13th, at 8:45 AM PT. On Thursday, November 21st at 8:00 AM ET, Mr. Hawkins will participate in a fireside chat discussion at the Canaccord Medtech, Diagnostics & Services Forum in New York City. A live and archived webcast of ...

November 5, 2024 1 EN
 PRESS RELEASE
Free
QSI QUANTUM-SI INC

Quantum-Si to Host Investor & Analyst Event in New York City on Novemb...

BRANFORD, Conn.--(BUSINESS WIRE)-- (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing Company™, today announced that the Company will host an Investor & Analyst event in New York City on November 20th, 2024. Quantum-Si’s management team will provide updates on the Company’s evolving technology roadmap, emerging applications for protein sequencing and the expanding commercial opportunities that these innovations create. A live question and answer session will follow the formal presentations. EVENT DETAILS: WHEN: Wednesday, November 20, 2024 | 10AM – 12PM EST WHERE...

October 31, 2024 1 EN
 PRESS RELEASE
Free
QSI QUANTUM-SI INC

Quantum-Si to Present at the 2024 American Society of Human Genetics A...

BRANFORD, Conn.--(BUSINESS WIRE)-- Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing Company™, today announced its attendance at the 2024 American Society of Human Genetics (ASHG) Annual Meeting, where it will host a sponsored talk on the role of Next-Generation Protein Sequencing (NGPS) in advancing genomics research. The presentation, titled “From Prediction to Protein: Validating Transcriptomics Data with Quantum-Si’s Next-Generation Protein Sequencing Technology,” features insights from both Quantum-Si and a leading academic researcher on...

October 30, 2024 1 EN
 PRESS RELEASE
Free
QSI QUANTUM-SI INC

Quantum-Si to Report Third Quarter 2024 Financial Results on Tuesday, ...

BRANFORD, Conn.--(BUSINESS WIRE)-- (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing CompanyTM, today announced that it will report financial results for the third quarter of 2024 on Tuesday, November 12, 2024. Company management will host a conference call to discuss financial results and provide a business update on the same day at 8:00 AM ET. Individuals interested in listening to the conference call may do so by joining the live webcast on the Investors section of the Quantum-Si website under . Alternatively, individuals can to receive a dial-in number and pe...

October 23, 2024 1 EN

ResearchPool Subscriptions

Get the most out of your insights

Get in touch